Nicholas Hanna to Feasibility Studies
This is a "connection" page, showing publications Nicholas Hanna has written about Feasibility Studies.
Connection Strength
0.299
-
Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular intervention. J Interv Cardiol. 2011 Jun; 24(3):278-84.
Score: 0.085
-
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial. Am Heart J. 2021 07; 237:25-33.
Score: 0.042
-
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. JACC Cardiovasc Interv. 2020 03 23; 13(6):726-735.
Score: 0.039
-
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis. JACC Cardiovasc Interv. 2020 05 11; 13(9):1019-1027.
Score: 0.039
-
TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial. JACC Cardiovasc Interv. 2019 05 27; 12(10):901-907.
Score: 0.036
-
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2018 10 30; 72(18):2095-2105.
Score: 0.035
-
Endovascular recanalization of central venous access to allow for pacemaker implantation or upgrade. Cardiovasc Revasc Med. 2012 Jul-Aug; 13(4):215-8.
Score: 0.023